The P-MAPP was developed by MediMergent LLC in collaboration with the US Food and Drug Administration. As a digital healthcare company, MediMergent collects real-world patient-centric data on medication safety, adherence/persistence and outcomes from key patient health data sources including medical records, pharmacy fill/refill records, medical insurance claims data and patient-reported outcome surveys. The company integrates digital technologies, analytics, and direct patient engagement to establish a comprehensive and robust database on patients’ behaviors related to health outcomes. MediMergent produces customized analytics and reporting to key stakeholders including patients, providers, payers, drug developers and regulatory agencies.